Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 373 results for "Byetta"

Efficacy and Tolerability of GLP-1 Agonists in T2DM

Amylin/Eli Lilly (2009) Byetta summary of product characteristics. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021773s9s11s18s22s25lbl.pdf [Accessed 8 May 2014]. Baggio, L. and Drucker, D. (2007) Biology of incretins: ... General Medicine eJournal, 2 weeks ago

Byetta-Drug Insights,2014

Summary 'Byetta - Drug Insights, 2014' provides Byetta marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent ...
 Individual.com1 month ago

Human medicines European public assessment report (EPAR): Byetta, exenatide, Revision: 15, Authorised

This is a summary of the European public assessment report (EPAR) for Byetta. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ...
 European Medicines Agency2 months ago
PRWeb

Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report

Hundreds of Byetta lawsuits (http://www.byettalawsuit2013.com/) and other product liability claims involving a class of Type 2 diabetes drugs known as incretin mimetics continue to move forward in a federal multidistrict litigation now underway in ...
 Digital Journal2 months ago Diabetes Drug Litigation Prepares to Discuss Byetta Lawsuits, Claims over Similar Products at December Conference, Bernstein Liebhard LLP Reports  Digital Journal2 months ago ASTRAZENECA : New Order Issued in Federal Incretin Mimetic Litigation, Where Hundreds of Byetta Lawsuits and other Diabetes Drug Claims Have Been Filed  4 Traders2 months ago New Order Issued in Federal Incretin Mimetic Litigation, Where Hundreds of Byetta Lawsuits and other Diabetes Drug Claims Have Been Filed  Red Orbit2 months ago
[x]  

exenatide, Byetta

Pharmacy Author: Omudhome Ogbru, PharmD Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University ...
 MedicineNet.com2 months ago Court Report - January 2015 #2  JD Supra1 month ago Court Report - December 2014 #4  JD Supra2 months ago
IOL

Could stress give you diabetes?

London The popular image of a patient with type 2 diabetes is someone who's overweight, with a couch-potato lifestyle. It's a stereotype that makes salesman Dave Dowdeswell furious. The father-of-two, now 48, developed the condition at the ...
 IOL11 hours ago Patient access to novel non-insulin treatments is sub-optimal in China  Pharma Letter2 months ago The Type 2 Diabetes Population will Continue to Expand in China, But Patient Access to Novel Non-Insulin Treatments is Sub-Optimal  Vision Monday2 months ago
[x]  

Diabetes Pen Devices to Display Additional Warning Labels

Share this article: The Food and Drug Administration (FDA) announced that multi-dose diabetes pen devices intended for single patient use only are now required to add additional label warnings prohibiting the sharing of these injectable ...
 Monthly Prescribing Reference2 days ago FDA Drug Safety Communication: FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients  U.S. Food and Drug Administration2 days ago

More Insight Into MannKind's Near-Term Profitability

Feb. 25, 2015 3:25 PM ET | About: MannKind Corporation (MNKD), Includes: SNY by: Psycho Analyst Summary The year-end 2014 conference call and presentation to analysts at the RBC Healthcare Conference provided a little more insight into the ...
 Seeking Alpha2 days ago
Jutia Group

Market Update (NYSE:BMY): Bristol-Myers Squibb Foundation Awards GRU Cancer Center Three-Year, $1.74M Grant to Address Lung Cancer Among Neediest Communities in Central Savannah River Area

[Business Wire] The Bristol-Myers Squibb Foundation today announced a three-year, $1.74 million grant to the GRU Cancer Center for a pilot program to reduce the burden of lung cancer among underserved populations in Georgia's Central Savannah River ...
 Jutia Group5 days ago BRISTOL MYERS SQUIBB CO - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.  Pharmacy Choice2 weeks ago Stock Update: Bristol-Myers Squibb Company (NYSE:BMY) Bristol-Myers Squibb to Take Part in Leerink Swann Global Health Care Conference  Jutia Group3 weeks ago Stock Update (NYSE:BMY): U.S. Food and Drug Administration Approves Bristol-Myers Squibb's Evotaz (atazanavir and cobicistat) for the Treatment of HIV-1 Infection in Adults  Jutia Group4 weeks ago

Capturing The Growth Of The Diabetic Epidemic Via Shares Of Novo Nordisk

Feb. 23, 2015 9:10 AM ET | About: Novo Nordisk A/S (NVO), Includes: AZN, GSK, LLY by: Alexander J. Poulos Summary Diabetes is at epidemic levels worldwide and growing. As the worlds population continues to age and become more sedentary, I ...
 Seeking Alpha5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less